Table 3.
Adipokines correlation with clinical and laboratory parameters in SSc patients with use of Spearman’s rank correlation test
| Disease characteristic | Chemerin | Visfatin | ||||
|---|---|---|---|---|---|---|
| Total SSc group | lcSSc | dcSSc | Total SSc group | lcSSc | dcSSc | |
| RP |
r = 0.21 p = 0.15 |
– | – |
r = –0.02 p = 0.25 |
– | – |
| Disease duration |
r = 0.07 p = 0.613 |
r = –0.02 p = 0.872 |
r = 0.371 p = 0.468 |
r = –0.17 p = 0.26 |
r = –0.14 p = 0.34 |
r = –0.60 p = 0.208 |
| mRSS |
r = –0.03 p = 0.80 |
r = 0.02 p = 0.859 |
r = –0.82 p = 0.04 |
r = 0.09 p = 0.53 |
r = 0.15 p = 0.32 |
r = –0.41 p = 0.41 |
| Disease activity index |
r = –0.27 p = 0.066 |
r = –0.22 p = 0.16 |
r = –0.20 p = 0.693 |
r = –0.053 p = 0.715 |
r = –0.064 p = 0.684 |
r = –0.23 p = 0.451 |
| Total cholesterol |
r = 0.09 p = 0.548 |
– | – |
r = –0.14 p = 0.335 |
– | – |
| HDL |
r = –0.13 p = 0.37 |
– | – |
r = –0.37 p = 0.009 |
– | – |
| LDL |
r = 0.15 p = 0.325 |
– | – |
r = 0.08 p = 0.60 |
– | – |
| TGL |
r = 0.3 p = 0.037 |
– | – |
r = 0.34 p = 0.019 |
– | – |
| BMI |
r = –0.07 p = 0.634 |
– | – |
r = 0.08 p = 0.574 |
– | – |
RP – Raynaud phenomenon – duration, HDL – high-density lipoprotein, LDL – low-density lipoprotein, TGL – triglycerides, BMI – body mass index.